LRMAX
Price
$27.65
Change
+$0.13 (+0.47%)
Updated
Sep 11 closing price
Net Assets
4.94B
VFIAX
Price
$708.02
Change
+$6.07 (+0.86%)
Updated
Sep 11 closing price
Net Assets
1.76T
Interact to see
Advertisement

LRMAX vs VFIAX

LRMAX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
LRMAX vs. VFIAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LRMAX is a Hold and VFIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.76T vs. LRMAX (4.94B). VFIAX pays higher dividends than LRMAX: VFIAX (1.03) vs LRMAX (0.81). LRMAX was incepted earlier than VFIAX: LRMAX (9 years) vs VFIAX (26 years). LRMAX (0.59) is less costly to investors than VFIAX (0.04). LRMAX is a more actively managed with annual turnover of: 30.00 vs. VFIAX (2.00). LRMAX has a lower initial minimum investment than VFIAX: LRMAX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 15.25 vs. LRMAX (6.52). VFIAX return over 5 years is better than : 70.39 vs. LRMAX (35.25).
LRMAXVFIAXLRMAX / VFIAX
Total Expense Ratio0.590.041,475%
Annual Report Gross Expense Ratio0.590.041,475%
Fund Existence9 years26 years-
Gain YTD8.09711.11573%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.94B1.76T0%
Annual Yield % from dividends0.811.0378%
Returns for 1 year6.5215.2543%
Returns for 3 years50.2570.2672%
Returns for 5 years35.2570.3950%
Returns for 10 yearsN/A258.35-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEVA29.011.05
+3.76%
CEVA
BIIB217.151.72
+0.80%
Biogen
LUCD0.78-0.02
-2.64%
Lucid Diagnostics
MBAI6.40-0.20
-3.03%
MBody AI Ltd
ELVN54.32-1.91
-3.40%
Enliven Therapeutics